|
Volumn 134, Issue 5 II, 1997, Pages
|
Successors to heparin: New antithrombotic agents
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
DALTEPARIN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
PLACEBO;
ACUTE HEART INFARCTION;
ANTICOAGULANT THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY THROMBOSIS;
DEEP VEIN THROMBOSIS;
DOUBLE BLIND PROCEDURE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOSIS PREVENTION;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
|
EID: 0031459903
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-8703(97)80052-x Document Type: Conference Paper |
Times cited : (14)
|
References (29)
|